Researchers are using imaging and diagnostic pathology to examine postmortem hearts donated by victims of COVID-19 to gain a better understanding of how the coronavirus that causes COVID-19 affects the heart.

Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA.

Vanderbilt Vaccine Center team isolates monoclonal antibodies against Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Researchers have developed a method to identify the primary interactions between incoming viral RNA genomes and host proteins.

Howard Price has a decades-old green notebook he keeps in his office at Vanderbilt University Medical Center, and when a shortage of a critical laboratory supply nearly brought testing for SARS-CoV-2, the virus that causes COVID-19, to a halt at the Medical Center, the notebook’s contents quickly became invaluable.

Monoclonal antibodies against Marburg virus — a more lethal cousin of the RNA virus that causes COVID-19 — may aid in the development of antibody “cocktails” to counter viral infection.